|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Serine protease inhibitor
|
 |
|
Title:
|
 |
Cleaved alpha-1-antitrypsin polymer
|
|
Structure:
|
 |
Alpha-1-antitrypsin. Chain: a. Fragment: residues 49-69,71-302,304-376. Synonym: alpha-1-proteinase inhibitor, alpha-1-pi. Engineered: yes. Mutation: yes. Alpha-1-antitrypsin. Chain: b. Fragment: residues 377-418.
|
|
Source:
|
 |
Homo sapiens. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.212
|
R-free:
|
0.258
|
|
|
Authors:
|
 |
J.A.Huntington,N.S.Pannu,B.Hazes,R.J.Read,D.A.Lomas,R.W.Carrell
|
Key ref:
|
 |
J.A.Huntington
et al.
(1999).
A 2.6 A structure of a serpin polymer and implications for conformational disease.
J Mol Biol,
293,
449-455.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Sep-99
|
Release date:
|
06-Feb-00
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
293:449-455
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
A 2.6 A structure of a serpin polymer and implications for conformational disease.
|
|
J.A.Huntington,
N.S.Pannu,
B.Hazes,
R.J.Read,
D.A.Lomas,
R.W.Carrell.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The function of the serpins as proteinase inhibitors depends on their ability to
insert the cleaved reactive centre loop as the fourth strand in the main A
beta-sheet of the molecule upon proteolytic attack at the reactive centre,
P1-P1'. This mechanism is vulnerable to mutations which result in inappropriate
intra- or intermolecular loop insertion in the absence of cleavage.
Intermolecular loop insertion is known as serpin polymerisation and results in a
variety of diseases, most notably liver cirrhosis resulting from mutations of
the prototypical serpin alpha1-antitrypsin. We present here the 2.6 A structure
of a polymer of alpha1-antitrypsin cleaved six residues N-terminal to the
reactive centre, P7-P6 (Phe352-Leu353). After self insertion of P14 to P7,
intermolecular linkage is affected by insertion of the P6-P3 residues of one
molecule into the partially occupied beta-sheet A of another. This results in an
infinite, linear polymer which propagates in the crystal along a 2-fold screw
axis. These findings provide a framework for understanding the uncleaved
alpha1-antitrypsin polymer and fibrillar and amyloid deposition of proteins seen
in other conformational diseases, with the ordered array of polymers in the
crystal resulting from slow accretion of the cleaved serpin over the period of a
year.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. (a) Monomer of the P7-P6 cleaved Pittsburgh
a[1]-antitrypsin in the classical view with b-sheet A in blue
and the portion of the reactive centre loop which becomes strand
4A after cleavage in red. The normal scissile bond (P1-P1') is
indicated by the arrow. Cleavage at this site results in a full
occupancy of b-sheet A with the inclusion of residues P15
through P3 as s4A. The P7 and P6 residues are indicated and are
separated by 70 Å. The effect of cleavage at P7-P6 is a
partial occupancy of the strand 4A allowing for ready insertion
of the residues C-terminal to the cleavage site, P6*-P3*, from
another monomer. (b) Such intermolecular loop insertion is
demonstrated in the structure of a tetramer extracted from the
infinite polymer, with the P6-P3 segment of one monomer clearly
visible within the b-sheet A of the other. Insertion is in
register with P1-P1' cleaved a[1]-antitrypsin. The monomers
which compose the polymer are related in the crystal by a
2[1]-fold screw axis parallel to the Image cell edge. (c) The
view down the 3[1]-fold screw axis of the crystal lattice
reveals its tube-like nature. The unusually high solvent content
of 73 % is explained by the 108 Å diameter hole that
extends for the length of the crystal. (d) The current model of
the uncleaved a[1]-antitrypsin trimer (magenta) [Elliott et al
1996 and Mahadeva et al 1999] and the structure of the cleaved
a[1]-antitrypsin trimer (cyan) in space-filling representation
after superposition of the first monomer. Polymerisation for the
uncleaved model is affected by in register insertion of the P8
to P3 of the reactive centre loop into the b-sheet A of the
following monomer. The model is thus constrained and cannot
adopt the conformation of the cleaved polymer with which it is
morphologically similar by electron microscopy. The Figures were
generated using Molscript [Kraulis 1991] and Raster3D [Bacon and
Anderson 1988 and Merritt and Murphy 1994].
|
 |
Figure 2.
Figure 2. (a) A stereo view of the cleaved a[1]-antitrypsin
dimer with a s[A]-weighted omit map, contoured at four times the
r.m.s. of the map, for the region extending from P15 to P5',
shows the unequivocal nature of the dimer contact. Continuous
density is observed for the entire length of strand 4A of the
black monomer into strand 1C of the next monomer in green. Weak
density is observed at the site of cleavage. (b) A close-up of
the omit map at the site of cleavage. P15 to P7 is in black with
P6* to P5'* of the dimer partner in green. The omit map was
computed after refinement using the model of cleaved
a[1]-antitrypsin with the reactive centre loop (P15-P5') removed.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
293,
449-455)
copyright 1999.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.R.Flotte,
and
C.Mueller
(2011).
Gene therapy for alpha-1 antitrypsin deficiency.
|
| |
Hum Mol Genet,
20,
R87-R92.
|
 |
|
|
|
|
 |
J.A.Huntington,
and
J.C.Whisstock
(2010).
Molecular contortionism - on the physical limits of serpin 'loop-sheet' polymers.
|
| |
Biol Chem,
391,
973-982.
|
 |
|
|
|
|
 |
U.I.Ekeowa,
J.Freeke,
E.Miranda,
B.Gooptu,
M.F.Bush,
J.Pérez,
J.Teckman,
C.V.Robinson,
and
D.A.Lomas
(2010).
Defining the mechanism of polymerization in the serpinopathies.
|
| |
Proc Natl Acad Sci U S A,
107,
17146-17151.
|
 |
|
|
|
|
 |
A.S.Knaupp,
and
S.P.Bottomley
(2009).
Serpin polymerization and its role in disease--the molecular basis of alpha1-antitrypsin deficiency.
|
| |
IUBMB Life,
61,
1-5.
|
 |
|
|
|
|
 |
B.Gooptu,
and
D.A.Lomas
(2009).
Conformational pathology of the serpins: themes, variations, and therapeutic strategies.
|
| |
Annu Rev Biochem,
78,
147-176.
|
 |
|
|
|
|
 |
B.Gooptu,
E.Miranda,
I.Nobeli,
M.Mallya,
A.Purkiss,
S.C.Brown,
C.Summers,
R.L.Phillips,
D.A.Lomas,
and
T.E.Barrett
(2009).
Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.
|
| |
J Mol Biol,
387,
857-868.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Garrett,
A.Fullaondo,
L.Troxler,
G.Micklem,
and
D.Gubb
(2009).
Identification and analysis of serpin-family genes by homology and synteny across the 12 sequenced Drosophilid genomes.
|
| |
BMC Genomics,
10,
489.
|
 |
|
|
|
|
 |
E.Miranda,
I.MacLeod,
M.J.Davies,
J.Pérez,
K.Römisch,
D.C.Crowther,
and
D.A.Lomas
(2008).
The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB.
|
| |
Hum Mol Genet,
17,
1527-1539.
|
 |
|
|
|
|
 |
R.W.Carrell,
A.Mushunje,
and
A.Zhou
(2008).
Serpins show structural basis for oligomer toxicity and amyloid ubiquity.
|
| |
FEBS Lett,
582,
2537-2541.
|
 |
|
|
|
|
 |
S.Granell,
G.Baldini,
S.Mohammad,
V.Nicolin,
P.Narducci,
B.Storrie,
and
G.Baldini
(2008).
Sequestration of Mutated {alpha}1-Antitrypsin into Inclusion Bodies Is a Cell-protective Mechanism to Maintain Endoplasmic Reticulum Function.
|
| |
Mol Biol Cell,
19,
572-586.
|
 |
|
|
|
|
 |
C.Liang,
P.Derreumaux,
and
G.Wei
(2007).
Structure and aggregation mechanism of beta(2)-microglobulin (83-99) peptides studied by molecular dynamics simulations.
|
| |
Biophys J,
93,
3353-3362.
|
 |
|
|
|
|
 |
L.D.Cabrita,
J.A.Irving,
M.C.Pearce,
J.C.Whisstock,
and
S.P.Bottomley
(2007).
Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap.
|
| |
J Biol Chem,
282,
26802-26809.
|
 |
|
|
|
|
 |
M.Kjellberg,
B.Rimac,
and
J.Stenflo
(2007).
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
|
| |
J Thromb Haemost,
5,
127-132.
|
 |
|
|
|
|
 |
P.C.Ong,
S.McGowan,
M.C.Pearce,
J.A.Irving,
W.T.Kan,
S.A.Grigoryev,
B.Turk,
G.A.Silverman,
K.Brix,
S.P.Bottomley,
J.C.Whisstock,
and
R.N.Pike
(2007).
DNA accelerates the inhibition of human cathepsin v by serpins.
|
| |
J Biol Chem,
282,
36980-36986.
|
 |
|
|
|
|
 |
P.Chowdhury,
W.Wang,
S.Lavender,
M.R.Bunagan,
J.W.Klemke,
J.Tang,
J.G.Saven,
B.S.Cooperman,
and
F.Gai
(2007).
Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides.
|
| |
J Mol Biol,
369,
462-473.
|
 |
|
|
|
|
 |
M.J.Bennett,
M.R.Sawaya,
and
D.Eisenberg
(2006).
Deposition diseases and 3D domain swapping.
|
| |
Structure,
14,
811-824.
|
 |
|
|
|
|
 |
R.H.Law,
Q.Zhang,
S.McGowan,
A.M.Buckle,
G.A.Silverman,
W.Wong,
C.J.Rosado,
C.G.Langendorf,
R.N.Pike,
P.I.Bird,
and
J.C.Whisstock
(2006).
An overview of the serpin superfamily.
|
| |
Genome Biol,
7,
216.
|
 |
|
|
|
|
 |
R.Nelson,
and
D.Eisenberg
(2006).
Recent atomic models of amyloid fibril structure.
|
| |
Curr Opin Struct Biol,
16,
260-265.
|
 |
|
|
|
|
 |
S.Skeldal,
J.V.Larsen,
K.E.Pedersen,
H.H.Petersen,
R.Egelund,
A.Christensen,
J.K.Jensen,
J.Gliemann,
and
P.A.Andreasen
(2006).
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
|
| |
FEBS J,
273,
5143-5159.
|
 |
|
|
|
|
 |
I.Nita,
C.Hollander,
U.Westin,
and
S.M.Janciauskiene
(2005).
Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
|
| |
Respir Res,
6,
12.
|
 |
|
|
|
|
 |
J.C.Whisstock,
S.P.Bottomley,
P.I.Bird,
R.N.Pike,
and
P.Coughlin
(2005).
Serpins 2005 - fun between the beta-sheets. Meeting report based upon presentations made at the 4th International Symposium on Serpin Structure, Function and Biology (Cairns, Australia).
|
| |
FEBS J,
272,
4868-4873.
|
 |
|
|
|
|
 |
D.A.Lomas,
and
H.Parfrey
(2004).
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.
|
| |
Thorax,
59,
529-535.
|
 |
|
|
|
|
 |
L.N.Benning,
J.C.Whisstock,
J.Sun,
P.I.Bird,
and
S.P.Bottomley
(2004).
The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.
|
| |
Protein Sci,
13,
1859-1864.
|
 |
|
|
|
|
 |
S.Janciauskiene,
S.Eriksson,
F.Callea,
M.Mallya,
A.Zhou,
K.Seyama,
S.Hata,
and
D.A.Lomas
(2004).
Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha1-antitrypsin.
|
| |
Hepatology,
40,
1203-1210.
|
 |
|
|
|
|
 |
S.Stefansson,
M.Yepes,
N.Gorlatova,
D.E.Day,
E.G.Moore,
A.Zabaleta,
G.A.McMahon,
and
D.A.Lawrence
(2004).
Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
|
| |
J Biol Chem,
279,
29981-29987.
|
 |
|
|
|
|
 |
E.M.Springhetti,
N.E.Istomina,
J.C.Whisstock,
T.Nikitina,
C.L.Woodcock,
and
S.A.Grigoryev
(2003).
Role of the M-loop and reactive center loop domains in the folding and bridging of nucleosome arrays by MENT.
|
| |
J Biol Chem,
278,
43384-43393.
|
 |
|
|
|
|
 |
E.Marszal,
D.Danino,
and
A.Shrake
(2003).
A novel mode of polymerization of alpha1-proteinase inhibitor.
|
| |
J Biol Chem,
278,
19611-19618.
|
 |
|
|
|
|
 |
N.Fay,
Y.Inoue,
L.Bousset,
H.Taguchi,
and
R.Melki
(2003).
Assembly of the yeast prion Ure2p into protein fibrils. Thermodynamic and kinetic characterization.
|
| |
J Biol Chem,
278,
30199-30205.
|
 |
|
|
|
|
 |
D.A.Lomas,
and
R.W.Carrell
(2002).
Serpinopathies and the conformational dementias.
|
| |
Nat Rev Genet,
3,
759-768.
|
 |
|
|
|
|
 |
J.A.Irving,
S.S.Shushanov,
R.N.Pike,
E.Y.Popova,
D.Brömme,
T.H.Coetzer,
S.P.Bottomley,
I.A.Boulynko,
S.A.Grigoryev,
and
J.C.Whisstock
(2002).
Inhibitory activity of a heterochromatin-associated serpin (MENT) against papain-like cysteine proteinases affects chromatin structure and blocks cell proliferation.
|
| |
J Biol Chem,
277,
13192-13201.
|
 |
|
|
|
|
 |
L.Bousset,
N.H.Thomson,
S.E.Radford,
and
R.Melki
(2002).
The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro.
|
| |
EMBO J,
21,
2903-2911.
|
 |
|
|
|
|
 |
M.K.Chow,
G.L.Devlin,
and
S.P.Bottomley
(2001).
Osmolytes as modulators of conformational changes in serpins.
|
| |
Biol Chem,
382,
1593-1599.
|
 |
|
|
|
|
 |
M.Yazaki,
J.J.Liepnieks,
J.R.Murrell,
M.Takao,
B.Guenther,
P.Piccardo,
M.R.Farlow,
B.Ghetti,
and
M.D.Benson
(2001).
Biochemical characterization of a neuroserpin variant associated with hereditary dementia.
|
| |
Am J Pathol,
158,
227-233.
|
 |
|
|
|
|
 |
S.Janciauskiene
(2001).
Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles.
|
| |
Biochim Biophys Acta,
1535,
221-235.
|
 |
|
|
|
|
 |
S.Nawata,
Y.Suminami,
H.Hirakawa,
A.Murakami,
K.Umayahara,
H.Ogata,
F.Numa,
K.Nakamura,
and
H.Kato
(2001).
Electrophoretic characterization of heat-stable squamous cell carcinoma antigen.
|
| |
Electrophoresis,
22,
3522-3526.
|
 |
|
|
|
|
 |
S.P.Bottomley,
I.D.Lawrenson,
D.Tew,
W.Dai,
J.C.Whisstock,
and
R.N.Pike
(2001).
The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
|
| |
Protein Sci,
10,
2518-2524.
|
 |
|
|
|
|
 |
R.Tranter,
J.A.Read,
R.Jones,
and
R.L.Brady
(2000).
Effector sites in the three-dimensional structure of mammalian sperm beta-acrosin.
|
| |
Structure,
8,
1179-1188.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |